Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lung Exposure of CHF 1535 NEXT DPI vs pMDI in Asthma
NCT01349257Phase 2Completed
- Sponsor
- Chiesi Farmaceutici S.p.A.
- Start
- May 2011
- Primary completion
- Jun 2011
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of beclometasone dipropionate + formoterol in asthma, sponsored by Chiesi Farmaceutici S.p.A.. Started May 2011; status: completed.
02
Drugs
beclometasone dipropionate + formoterol
03
Conditions
asthma
Beyond the preview
Go deeper on NCT01349257.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01349257.